These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27388466)

  • 1. Increased Plasma Levels of Select Deoxy-ceramide and Ceramide Species are Associated with Increased Odds of Diabetic Neuropathy in Type 1 Diabetes: A Pilot Study.
    Hammad SM; Baker NL; El Abiad JM; Spassieva SD; Pierce JS; Rembiesa B; Bielawski J; Lopes-Virella MF; Klein RL;
    Neuromolecular Med; 2017 Mar; 19(1):46-56. PubMed ID: 27388466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
    Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
    Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes.
    Klein RL; Hammad SM; Baker NL; Hunt KJ; Al Gadban MM; Cleary PA; Virella G; Lopes-Virella MF;
    Metabolism; 2014 Oct; 63(10):1287-95. PubMed ID: 25088746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipid changes in mouse brain and plasma after mild traumatic brain injury at the acute phases.
    Mondal K; Del Mar NA; Gary AA; Grambergs RC; Yousuf M; Tahia F; Stephenson B; Stephenson DJ; Chalfant CE; Reiner A; Mandal N
    Lipids Health Dis; 2024 Jun; 23(1):200. PubMed ID: 38937745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral sphingolipids are associated with variation in white matter microstructure in older adults.
    Gonzalez CE; Venkatraman VK; An Y; Landman BA; Davatzikos C; Ratnam Bandaru VV; Haughey NJ; Ferrucci L; Mielke MM; Resnick SM
    Neurobiol Aging; 2016 Jul; 43():156-63. PubMed ID: 27255825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingolipids signature in plasma and tissue as diagnostic and prognostic tools in oral squamous cell carcinoma.
    Faedo RR; da Silva G; da Silva RM; Ushida TR; da Silva RR; Lacchini R; Matos LL; Kowalski LP; Lopes NP; Leopoldino AM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159057. PubMed ID: 34655810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity.
    Hammad SM; Hardin JR; Wilson DA; Twal WO; Nietert PJ; Oates JC
    PLoS One; 2019; 14(11):e0224496. PubMed ID: 31747417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathy in the DCCT/EDIC-What Was Done Then and What We Would Do Better Now.
    Pop-Busui R; Martin C
    Int Rev Neurobiol; 2016; 127():9-25. PubMed ID: 27133142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.
    Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Kuo MS; Perreault L
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E398-408. PubMed ID: 26126684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications.
    Herman WH; Pop-Busui R; Braffett BH; Martin CL; Cleary PA; Albers JW; Feldman EL;
    Diabet Med; 2012 Jul; 29(7):937-44. PubMed ID: 22417277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary sphingolipids in adolescents and young adults with youth-onset diabetes.
    Nehus EJ; Sheanon NM; Zhang W; Marcovina SM; Setchell KDR; Mitsnefes MM
    Pediatr Nephrol; 2024 Jun; 39(6):1875-1883. PubMed ID: 38172468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Sphingolipids and All-Cause Mortality: The Strong Heart Family Study.
    Fretts AM; Jensen PN; Sitlani CM; Hoofnagle A; Lidgard B; Umans JG; Siscovick DS; King IB; Howard BV; Cole SA; Lemaitre RN
    J Am Heart Assoc; 2024 Jul; 13(13):e032536. PubMed ID: 38904223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy?
    Othman A; Benghozi R; Alecu I; Wei Y; Niesor E; von Eckardstein A; Hornemann T
    J Clin Lipidol; 2015; 9(4):568-75. PubMed ID: 26228675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widespread tissue distribution and synthetic pathway of polyunsaturated C24:2 sphingolipids in mammals.
    Edagawa M; Sawai M; Ohno Y; Kihara A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Dec; 1863(12):1441-1448. PubMed ID: 30251650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance.
    Haus JM; Kashyap SR; Kasumov T; Zhang R; Kelly KR; Defronzo RA; Kirwan JP
    Diabetes; 2009 Feb; 58(2):337-43. PubMed ID: 19008343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Ceramide Species Are Associated with Diabetes Risk in Participants of the Strong Heart Study.
    Fretts AM; Jensen PN; Hoofnagle A; McKnight B; Howard BV; Umans J; Yu C; Sitlani C; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
    J Nutr; 2020 May; 150(5):1214-1222. PubMed ID: 31665380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deoxysphingoid bases as plasma markers in diabetes mellitus.
    Bertea M; Rütti MF; Othman A; Marti-Jaun J; Hersberger M; von Eckardstein A; Hornemann T
    Lipids Health Dis; 2010 Aug; 9():84. PubMed ID: 20712864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in plasma levels of long chain and very long chain ceramides between African Americans and whites: An observational study.
    Buie JNJ; Hammad SM; Nietert PJ; Magwood G; Adams RJ; Bonilha L; Sims-Robinson C
    PLoS One; 2019; 14(5):e0216213. PubMed ID: 31067249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
    Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
    Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study.
    Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Howard BV; Umans JG; Sitlani CM; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
    Cardiovasc Diabetol; 2022 Aug; 21(1):167. PubMed ID: 36042511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.